{
    "nct_id": "NCT03467477",
    "title": "A Multicenter Screening Study With Flortaucipir F 18 in Patients With Early Symptomatic AD; #2",
    "status": "COMPLETED",
    "last_update_time": "2020-08-07",
    "description_brief": "This protocol is designed to serve as a pre-screening study for subjects who are potentially eligible for Alzheimer's Disease (AD) therapeutic trials that require tau imaging for inclusion by means of a flortaucipir F18 Positron Emission Tomography (PET) scan.",
    "description_detailed": "N/A",
    "phase": [
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "DIAGNOSTIC",
    "results": {
        "participantFlowModule": {
            "recruitmentDetails": "Enrollment occurred between Mar 2018 and Nov 2018. Recruited subjects with clinically diagnosed early AD who were interested in participating in AD therapeutic clinical trials being conducted by Eli Lilly and Company.",
            "groups": [
                {
                    "id": "FG000",
                    "title": "Early Symptomatic AD Subjects",
                    "description": "Early Symptomatic AD subjects in the flortaucipir PET scan arm"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "161"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "161"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Early Symptomatic AD Subjects",
                    "description": "Early Symptomatic AD subjects in the flortaucipir PET scan arm"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "161"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "75.0",
                                            "spread": "6.0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "93"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "68"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "3"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "4"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "154"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "MMSE",
                    "description": "Mini-mental status exam (MMSE) is a 30-point questionnaire that is used to measure cognitive impairment. Scores range from 0 to 30 with lower scores representing greater levels of cognitive impairment.",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "units on a scale",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "25.0",
                                            "spread": "2.51"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Flortaucipir Qualitative Results (Visual Reads)",
                    "description": "Flortaucipir PET scans were rated visually by an expert reader as follows: Not consistent with an AD pattern (\u03c4AD-), Moderate AD pattern (\u03c4AD+), or Advanced AD pattern and likely to progress (\u03c4AD++). Eligibility for future studies was determined from the flortaucipir PET scan according to protocol-specified criteria.",
                    "reportingStatus": "POSTED",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "timeFrame": "baseline scan",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Early Symptomatic AD, Eligible for Future Trials",
                            "description": "Subjects determined to be eligible for future studies from the flortaucipir PET scan arm."
                        },
                        {
                            "id": "OG001",
                            "title": "Early Symptomatic AD, Ineligible for Future Trials",
                            "description": "Subjects who were not eligible for future studies from the flortaucipir PET scan arm."
                        },
                        {
                            "id": "OG002",
                            "title": "Early Symptomatic AD, Not Evaluable",
                            "description": "Subjects determined to be not eligible for future studies from the flortaucipir PET scan arm due to unevaluable PET scan for quantitation"
                        },
                        {
                            "id": "OG003",
                            "title": "Early Symptomatic AD (Total)",
                            "description": "All subjects with early symptomatic AD from the flortaucipir PET scan arm"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "55"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "105"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "1"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "161"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "\u03c4AD++, advanced AD pattern",
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "51"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "65"
                                        }
                                    ]
                                },
                                {
                                    "title": "\u03c4AD+, moderate AD pattern",
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "14"
                                        }
                                    ]
                                },
                                {
                                    "title": "\u03c4AD-, pattern not consistent with AD",
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "82"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "82"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Flortaucipir Quantitative Results (SUVr)",
                    "description": "Flortaucipir standardized uptake value ratio (SUVr). A value of 1 signifies no flortaucipir activity above background, values greater than 1 signify increasing flortaucipir activity in the brain. Visual read categories as described for previous measure.",
                    "populationDescription": "SUVr was not collected for patients with a \u03c4AD- result (n=82) and one subject had an unevaluable flortaucipir scan for quantitation. Therefore, analysis population n=78.",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "standardized uptake value ratio (SUVr)",
                    "timeFrame": "baseline scan",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Early Symptomatic AD, Eligible for Future Trials",
                            "description": "Subjects determined to be eligible for future studies from the flortaucipir PET scan arm."
                        },
                        {
                            "id": "OG001",
                            "title": "Early Symptomatic AD, Ineligible for Future Trials",
                            "description": "Subjects who were not eligible for future studies from the flortaucipir PET scan arm."
                        },
                        {
                            "id": "OG002",
                            "title": "Early Symptomatic AD, Not Evaluable",
                            "description": "Subjects determined to be not eligible for future studies from the flortaucipir PET scan arm due to unevaluable PET scan for quantitation"
                        },
                        {
                            "id": "OG003",
                            "title": "Early Symptomatic AD (Total)",
                            "description": "All subjects with early symptomatic AD from the flortaucipir PET scan arm"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "55"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "23"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "1"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "78"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "title": "SUVr all subjects",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "55"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "23"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "78"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.24766",
                                            "spread": "0.122786"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.38020",
                                            "spread": "0.343791"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "1.28674",
                                            "spread": "0.219185"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SUVr \u03c4AD++ subjects",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "51"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "64"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.25687",
                                            "spread": "0.122501"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.64935",
                                            "spread": "0.187100"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "1.33659",
                                            "spread": "0.209539"
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "title": "SUVr \u03c4AD+ subjects",
                            "denoms": [
                                {
                                    "units": "Participants",
                                    "counts": [
                                        {
                                            "groupId": "OG000",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "14"
                                        }
                                    ]
                                }
                            ],
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.13025",
                                            "spread": "0.038043"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "1.03031",
                                            "spread": "0.039727"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "1.05886",
                                            "spread": "0.060181"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "1",
            "timeFrame": "48 hours after study drug administration",
            "description": "Adverse events (AEs) were collected at scan visits, regardless of attribution to study drug. End of study for AE reporting was 48 hours after the last study drug administration. AEs occurring after study drug administration, but outside that window were not recorded, unless considered attributable to study drug.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Safety Analysis Population",
                    "description": "All subjects with early symptomatic AD from the flortaucipir PET scan arm who received one dose of flortaucipir",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 161,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 161,
                    "otherNumAffected": 2,
                    "otherNumAtRisk": 161
                }
            ],
            "otherEvents": [
                {
                    "term": "claustrophobia",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 21.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 161
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictionType": "LTE60",
                "restrictiveAgreement": true
            },
            "pointOfContact": {
                "title": "Medical Director",
                "organization": "Avid Radiopharmaceuticals, Inc.",
                "email": "clinicaloperations@avidrp.com",
                "phone": "215-298-0700"
            }
        }
    },
    "target_category": "N/A",
    "drug": [
        "Flortaucipir F18 (Tauvid)"
    ],
    "placebo": [],
    "explanation_target": [
        "Reason: The protocol describes a pre-screening study that uses flortaucipir F18 PET (tau imaging) to identify subjects for Alzheimer\u2019s therapeutic trials \u2014 this is a diagnostic imaging procedure, not a therapeutic intervention aimed at modifying disease pathology or improving cognition/behavior. Therefore it does not fit any of the four therapeutic categories (disease-targeted biologic, disease-targeted small molecule, cognitive enhancer, or neuropsychiatric symptom improvement). \ue200cite\ue202turn0search6\ue202turn0search0\ue201",
        "Act (key details extracted): The study title and description explicitly state use of flortaucipir F18 (branded TAUVID) for tau PET imaging in early symptomatic AD. Flortaucipir F18 selectively binds aggregated tau neurofibrillary tangles and is an FDA\u2011approved radioactive diagnostic PET agent indicated to estimate the density and distribution of tau NFTs in adults being evaluated for Alzheimer\u2019s disease. This confirms the intervention is diagnostic (imaging), not a therapeutic drug. \ue200cite\ue202turn0search1\ue202turn0search5\ue201",
        "Web search results (sources found): FDA announcement approving Tauvid (flortaucipir F18) as a PET tracer for imaging tau pathology in patients evaluated for AD. \ue200cite\ue202turn0search6\ue201 Lilly product/site pages describing TAUVID (flortaucipir F18) indications, mechanism (selective binding to aggregated tau), test accuracy, and prescribing information. \ue200cite\ue202turn0search0\ue202turn0search2\ue201 A Lilly press release noting FDA approval (May 28, 2020) and developer information. \ue200cite\ue202turn0search1\ue201",
        "Reflect: Classification check \u2014 because the study\u2019s intervention is a diagnostic PET radiotracer (flortaucipir F18 / TAUVID) used to image tau pathology and to screen/enroll participants, it does not represent a biologic or small-molecule therapeutic, nor a cognitive enhancer or symptom-targeting treatment. The correct category is therefore 'N/A'. Citations above support that flortaucipir F18 is a diagnostic imaging agent rather than a therapeutic. \ue200cite\ue202turn0search5\ue202turn0search6\ue201"
    ],
    "agent_type": "N/A",
    "explanation_agent": []
}